HanAll Biopharma Co., Ltd., a global biopharmaceutical company committed to discovering and developing innovative medicines for patients, is now accepting applications for the 2023 pharmaceutical industry fellowship program through April 15, 2023. The program is open to physicians trained in Indonesia, who have a strong interest in working for a global biopharma company.
The Pharmaceutical Industry Fellowship Program, which runs from September 2023 to September 2025, offers intensive training to grow into global drug development experts. Participants will rotate every six months among four main arenas of drug development including clinical development and project management, operations and regulatory affairs, preclinical development and CMC, and business development.
The fellows will also receive education through DIA learning, experienced mentoring, as well as hands-on experience working in a biopharmaceutical company.
“Our fellowship program fosters next generation research leaders contributing to discovering and developing innovative therapies for patients. The fellows have the opportunity to explore the wide range of roles and workstreams involved in taking a therapy from discovery to commercialization and emerge positioned for a variety of careers in biotechnology and pharma, while providing additional layers of thoughts and perspectives to our team,” said Almira Chabi, M.D., Chief Medical Officer and Chief Development Officer at HanAll.